Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Sensitisation data (human)

Currently viewing:

Administrative data

Endpoint:
sensitisation data (humans)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
17 December 2008 to 30 January 2009
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Type of sensitisation studied:
skin
Study type:
study with volunteers
Principles of method if other than guideline:
Although not stated, the procedure used was essentially that of Draize (Procedures for the appraisal of the toxicity of chemicals in foods, drugs, and cosmetics. VIII. Dermal toxicity, Food Drug Cosmetic Law J. 10:722-731, 1955).
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
431-090-3
EC Name:
-
Cas Number:
190085-41-7
Molecular formula:
C19 H30 O3
IUPAC Name:
2-butyloctyl 2-hydroxybenzoate

Method

Type of population:
not specified
Ethical approval:
not specified
Subjects:
Fifty-six (56) male and female
Route of administration:
dermal
Details on study design:
Participants:

Fifty-six (56) male and female subjects ranging in age from 19 to 78 years of age. Fifty-two (52) subjects completed the study. The remaining subjects discontinued their participation for various reasons, none of which were related to the application of the test material.

Inclusion Criteria:

The following criteria applied to study participants: male and female, age 16 or older; an absence of any visible skin disease which might confuse the study results; prohibition on the use of topical or systemic steroids and/or antihistamines for at least seven days prior to study initiation; completion of medical history forms and informed consent forms; considered reliable and capable of following directions.

Exclusion Criteria:

The following applied: ill health; someone under a doctor's care and taking medication that might influence the outcome of the study; pregnant or nursing females; a history of adverse reactions to cosmetics or other personal care products.

Results and discussion

Results of examinations:
Under the conditions of this study, the test material did not indicate a potential for dermal irritation or allergic contact sensitization.

Applicant's summary and conclusion

Conclusions:
Under the conditions of this study, the test material did not indicate a potential for dermal irritation or allergic contact sensitization.